|
|
| DYR_BOVIN |
DHFR |
Dihydrofolate reductase |
1.279e-131 |
0.55
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
1.597e-106 |
0.37
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
3.195e-101 |
0.35
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
1.761e-98 |
0.36
|
| CCR4_MOUSE |
Ccr4 |
C-C chemokine receptor type 4 |
1.339e-92 |
0.41
|
| EHMT2_HUMAN |
EHMT2 |
Histone-lysine N-methyltransferase EHMT2 |
2.283e-77 |
0.37
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
1.059e-67 |
0.35
|
| CALCA_HUMAN |
CALCA |
Calcitonin gene-related peptide 1 |
1.675e-62 |
0.35
|
| PORCN_MOUSE |
Porcn |
Protein-serine O-palmitoleoyltransferase porcupine |
4.932e-62 |
0.38
|
| TRPV4_RAT |
Trpv4 |
Transient receptor potential cation channel subfamily V member 4 |
1.084e-57 |
0.36
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
3.456e-56 |
0.35
|
| KMT5A_HUMAN |
KMT5A |
N-lysine methyltransferase KMT5A |
3.036e-50 |
0.30
|
| EHMT1_HUMAN |
EHMT1 |
Histone-lysine N-methyltransferase EHMT1 |
3.643e-50 |
0.33
|
| CASB_RAT |
Csn2 |
Beta-casein |
4.508e-43 |
0.33
|
| TLR4_MOUSE |
Tlr4 |
Toll-like receptor 4 |
2.409e-41 |
0.38
|
| D4ADR1_RAT |
Lpar5 |
Lysophosphatidic acid receptor 5 |
5.06e-41 |
0.33
|
| LMBL4_HUMAN |
L3MBTL4 |
Lethal(3)malignant brain tumor-like protein 4 |
4.067e-39 |
0.31
|
| VDAC2_HUMAN |
VDAC2 |
Voltage-dependent anion-selective channel protein 2 |
7.142e-37 |
0.29
|
| CALRL_HUMAN |
CALCRL |
Calcitonin gene-related peptide type 1 receptor |
3.587e-34 |
0.36
|
| HPPD_HUMAN |
HPD |
4-hydroxyphenylpyruvate dioxygenase |
1.044e-30 |
0.34
|
| CCR4_HUMAN |
CCR4 |
C-C chemokine receptor type 4 |
1.63e-30 |
0.41
|
| Q8WQX9_9TRYP |
PDEB1 |
Phosphodiesterase |
1.325e-29 |
0.30
|
| OPRX_RAT |
Oprl1 |
Nociceptin receptor |
3.053e-29 |
0.31
|
| PDE10_MOUSE |
Pde10a |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
4.636e-29 |
0.31
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
1.124e-26 |
0.33
|
| ADA2A_PIG |
ADRA2A |
Alpha-2A adrenergic receptor |
4.502e-26 |
0.32
|
| BKRB1_MACFA |
BDKRB1 |
B1 bradykinin receptor |
8.314e-26 |
0.30
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
6.491e-25 |
0.42
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
1.144e-24 |
0.36
|
| ADA1A_RAT |
Adra1a |
Alpha-1A adrenergic receptor |
9.938e-24 |
0.41
|
| TLR4_HUMAN |
TLR4 |
Toll-like receptor 4 |
1.413e-23 |
0.38
|
| C3SLB7_ECOLX |
glmU |
Bifunctional protein GlmU |
2.821e-22 |
0.30
|
| MET_HUMAN |
MET |
Hepatocyte growth factor receptor |
3.261e-22 |
0.36
|
| TRPV4_HUMAN |
TRPV4 |
Transient receptor potential cation channel subfamily V member 4 |
5.193e-22 |
0.36
|
| ADA1D_RAT |
Adra1d |
Alpha-1D adrenergic receptor |
8.381e-22 |
0.36
|
| TGM2_HUMAN |
TGM2 |
Protein-glutamine gamma-glutamyltransferase 2 |
1.197e-21 |
0.37
|
| XCT_HUMAN |
SLC7A11 |
Cystine/glutamate transporter |
7.218e-21 |
0.29
|
| O70424_RAT |
|
Neuropeptide Y-Y2 receptor |
3.68e-20 |
0.32
|
| Q5TKS5_STAAU |
fabI |
Enoyl-ACP reductase |
6.478e-20 |
0.35
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
4.571e-19 |
0.37
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
4.766e-19 |
0.37
|
| KC1D_RAT |
Csnk1d |
Casein kinase I isoform delta |
5.245e-19 |
0.36
|
| FKBP5_HUMAN |
FKBP5 |
Peptidyl-prolyl cis-trans isomerase FKBP5 |
8.226e-19 |
0.31
|
| Q1HEC0_RAT |
|
Acetyl-Coenzyme A carboxylase 2 |
9.376e-19 |
0.30
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
1.893e-18 |
0.41
|
| AUKBA_XENLA |
aurkb-a |
Aurora kinase B-A |
2.139e-18 |
0.29
|
| PGFRB_HUMAN |
PDGFRB |
Platelet-derived growth factor receptor beta |
2.464e-18 |
0.32
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
5.301e-18 |
0.41
|
| NEMO_HUMAN |
IKBKG |
NF-kappa-B essential modulator |
1.468e-17 |
0.34
|
| TNFA_HUMAN |
TNF |
Tumor necrosis factor |
1.537e-17 |
0.36
|
| Q9R1L2_MICOH |
OTR |
Oxytocin receptor |
6.661e-16 |
0.30
|
| V1AR_MICOH |
Avpr1a |
Vasopressin V1a receptor |
6.661e-16 |
0.30
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
3.22e-15 |
0.36
|
| NK1R_MOUSE |
Tacr1 |
Substance-P receptor |
3.775e-15 |
0.29
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
6.106e-15 |
0.36
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
2.254e-14 |
0.36
|
| NMDE4_RAT |
Grin2d |
Glutamate receptor ionotropic, NMDA 2D |
4.141e-14 |
0.33
|
| PDE5A_CANLF |
PDE5A |
cGMP-specific 3',5'-cyclic phosphodiesterase |
1.613e-13 |
0.35
|
| MIP_LEGPN |
mip |
Outer membrane protein MIP |
3.113e-13 |
0.31
|
| GPBAR_MOUSE |
Gpbar1 |
G-protein coupled bile acid receptor 1 |
6.508e-13 |
0.31
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
3.115e-12 |
0.36
|
| ATG4B_HUMAN |
ATG4B |
Cysteine protease ATG4B |
4.097e-12 |
0.40
|
| BKRB1_RAT |
Bdkrb1 |
B1 bradykinin receptor |
4.219e-12 |
0.30
|
| VGFR2_MOUSE |
Kdr |
Vascular endothelial growth factor receptor 2 |
4.99e-12 |
0.32
|
| PDE4B_HUMAN |
PDE4B |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B |
1.177e-11 |
0.34
|
| ELAV1_HUMAN |
ELAVL1 |
ELAV-like protein 1 |
1.93e-11 |
0.31
|
| MDR1B_MOUSE |
Abcb1b |
ATP-dependent translocase ABCB1 |
2.965e-11 |
0.30
|
| P2Y12_HUMAN |
P2RY12 |
P2Y purinoceptor 12 |
3.452e-11 |
0.35
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
9.856e-11 |
0.29
|
| PI3R5_HUMAN |
PIK3R5 |
Phosphoinositide 3-kinase regulatory subunit 5 |
1.235e-10 |
0.28
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
1.525e-10 |
0.33
|
| HCN4_HUMAN |
HCN4 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
4.042e-10 |
0.29
|
| V1BR_HUMAN |
AVPR1B |
Vasopressin V1b receptor |
4.483e-10 |
0.31
|
| CAC1B_RAT |
Cacna1b |
Voltage-dependent N-type calcium channel subunit alpha-1B |
4.722e-10 |
0.32
|
| O96526_LEIMA |
CRK3 |
Cdc2-related kinase |
5.242e-10 |
0.29
|
| EPHA2_HUMAN |
EPHA2 |
Ephrin type-A receptor 2 |
7.34e-10 |
0.30
|
| OPRK_RAT |
Oprk1 |
Kappa-type opioid receptor |
1.828e-09 |
0.31
|
| INSR_HUMAN |
INSR |
Insulin receptor |
2.813e-09 |
0.31
|
| IBP5_HUMAN |
IGFBP5 |
Insulin-like growth factor-binding protein 5 |
2.851e-09 |
0.29
|
| EBP_CAVPO |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
3.302e-09 |
0.35
|
| IF4H_HUMAN |
EIF4H |
Eukaryotic translation initiation factor 4H |
3.852e-09 |
0.32
|
| NK2R_RABIT |
TACR2 |
Substance-K receptor |
4.459e-09 |
0.30
|
| NTR1_HUMAN |
NTSR1 |
Neurotensin receptor type 1 |
4.577e-09 |
0.33
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
6.269e-09 |
0.35
|
| ACES_ANOGA |
Ace |
Acetylcholinesterase |
6.363e-09 |
0.33
|
| MTR1B_HUMAN |
MTNR1B |
Melatonin receptor type 1B |
7.089e-09 |
0.35
|
| HRH3_MOUSE |
Hrh3 |
Histamine H3 receptor |
1.237e-08 |
0.32
|
| PA21B_HUMAN |
PLA2G1B |
Phospholipase A2 |
1.312e-08 |
0.40
|
| PDE7A_HUMAN |
PDE7A |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A |
1.609e-08 |
0.40
|
| PDE8A_HUMAN |
PDE8A |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A |
2.548e-08 |
0.31
|
| Q8MHZ5_SHEEP |
|
Ghrelin/growth hormone secretagogue receptor |
2.555e-08 |
0.31
|
| CHLE_HORSE |
BCHE |
Cholinesterase |
2.792e-08 |
0.33
|
| HIF1A_HUMAN |
HIF1A |
Hypoxia-inducible factor 1-alpha |
3.749e-08 |
0.33
|
| FDFT_HUMAN |
FDFT1 |
Squalene synthase |
5.653e-08 |
0.33
|
| PGH1_SHEEP |
PTGS1 |
Prostaglandin G/H synthase 1 |
6.374e-08 |
0.41
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
7.689e-08 |
0.33
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
8.582e-08 |
0.36
|
| EPHB4_HUMAN |
EPHB4 |
Ephrin type-B receptor 4 |
1.086e-07 |
0.30
|
| CFAD_HUMAN |
CFD |
Complement factor D |
1.93e-07 |
0.33
|
| KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
3.218e-07 |
0.42
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
3.668e-07 |
0.34
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
3.696e-07 |
0.35
|
| MK07_HUMAN |
MAPK7 |
Mitogen-activated protein kinase 7 |
3.857e-07 |
0.35
|
| RCE1_YEAST |
RCE1 |
CAAX prenyl protease 2 |
4.564e-07 |
0.34
|
| NMDE3_RAT |
Grin2c |
Glutamate receptor ionotropic, NMDA 2C |
5.554e-07 |
0.33
|
| CHLE_HUMAN |
BCHE |
Cholinesterase |
5.939e-07 |
0.32
|
| IGF1R_HUMAN |
IGF1R |
Insulin-like growth factor 1 receptor |
6.728e-07 |
0.31
|
| EGFR_HUMAN |
EGFR |
Epidermal growth factor receptor |
8.7e-07 |
0.34
|
| ACES_ELEEL |
ache |
Acetylcholinesterase |
8.712e-07 |
0.36
|
| PGFRB_MOUSE |
Pdgfrb |
Platelet-derived growth factor receptor beta |
8.89e-07 |
0.32
|
| PDE11_HUMAN |
PDE11A |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A |
8.962e-07 |
0.34
|
| ACES_BOVIN |
ACHE |
Acetylcholinesterase |
9.925e-07 |
0.31
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
1.166e-06 |
0.28
|
| PK3CD_MOUSE |
Pik3cd |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform |
1.25e-06 |
0.29
|
| FDFT_RAT |
Fdft1 |
Squalene synthase |
1.407e-06 |
0.29
|
| ALBU_BOVIN |
ALB |
Serum albumin |
2.07e-06 |
0.28
|
| PORCN_HUMAN |
PORCN |
Protein-serine O-palmitoleoyltransferase porcupine |
2.802e-06 |
0.36
|
| CP3A4_HUMAN |
CYP3A4 |
Cytochrome P450 3A4 |
2.869e-06 |
0.40
|
| A4_HUMAN |
APP |
Amyloid-beta precursor protein |
4.714e-06 |
0.30
|
| MCLN3_HUMAN |
MCOLN3 |
Mucolipin-3 |
4.786e-06 |
0.32
|
| CP2C9_HUMAN |
CYP2C9 |
Cytochrome P450 2C9 |
5.026e-06 |
0.40
|
| ALK_HUMAN |
ALK |
ALK tyrosine kinase receptor |
5.128e-06 |
0.31
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
5.163e-06 |
0.32
|
| JUN_HUMAN |
JUN |
Transcription factor AP-1 |
5.724e-06 |
0.32
|
| PPBN_HUMAN |
ALPG |
Alkaline phosphatase, germ cell type |
6.243e-06 |
0.32
|
| PRIO_HUMAN |
PRNP |
Major prion protein |
6.528e-06 |
0.32
|
| PDE10_HUMAN |
PDE10A |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
7.193e-06 |
0.37
|
| OXYR_HUMAN |
OXTR |
Oxytocin receptor |
7.279e-06 |
0.31
|
| PDE3A_HUMAN |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
7.677e-06 |
0.33
|
| MRGX1_RAT |
Mrgprx1 |
Mas-related G-protein coupled receptor member X1 |
8.03e-06 |
0.29
|
| E2AK3_HUMAN |
EIF2AK3 |
Eukaryotic translation initiation factor 2-alpha kinase 3 |
8.325e-06 |
0.30
|